Clinical and laboratory directions for ovarian cancer research

Linking genomic reorganization to tumor initiation via the giant cell cycle.

Oncogenesis·2016

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Oncogene·2015

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.

Cell death & disease·2015

ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.

Cell death and differentiation·2014

Molecular approaches to personalizing management of ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.

Oncogene·2011

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Gynecologic oncology·2026

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Gynecologic oncology·2026

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Gynecologic oncology·2026

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Gynecologic oncology·2026

Molecular characterization of NSMP endometrial cancer and its relevance for treatment.

Gynecologic oncology·2026

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Gynecologic oncology·2026

Reduced Arpc1b expression in astrocytes is associated with cytoskeletal remodeling, ALDOA redistribution, glycolysis, and neuroinflammation in a mouse model of bone cancer pain.

Translational cancer research·2026

Myocardial infarction and lung cancer research from 1995 to 2026: a WoSCC- and PubMed-based bibliometric analysis.

Journal of thoracic disease·2026

Procyanidin C1 combined with olaparib induces senescence in BRCA1-proficient breast cancer cells.

American journal of cancer research·2026

Erratum: DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.

American journal of cancer research·2026

CircFN1 promotes invasion of papillary thyroid carcinoma cells by activating the PI3K/AKT pathway via the miR-29a/TRIB2 axis.

Translational cancer research·2026

The potential role of NLRP3 inflammasome in integrating redox, metabolic, and inflammatory signals during follicular development: a hypothesis-driven redox-metabolic integrator framework.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

Clinical and laboratory directions for ovarian cancer research

Related Concept Videos

Linking genomic reorganization to tumor initiation via the giant cell cycle.

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.

ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.

Molecular approaches to personalizing management of ovarian cancer.

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Molecular characterization of NSMP endometrial cancer and its relevance for treatment.

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Reduced Arpc1b expression in astrocytes is associated with cytoskeletal remodeling, ALDOA redistribution, glycolysis, and neuroinflammation in a mouse model of bone cancer pain.

Myocardial infarction and lung cancer research from 1995 to 2026: a WoSCC- and PubMed-based bibliometric analysis.

Procyanidin C1 combined with olaparib induces senescence in BRCA1-proficient breast cancer cells.

Erratum: DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.

CircFN1 promotes invasion of papillary thyroid carcinoma cells by activating the PI3K/AKT pathway via the miR-29a/TRIB2 axis.

The potential role of NLRP3 inflammasome in integrating redox, metabolic, and inflammatory signals during follicular development: a hypothesis-driven redox-metabolic integrator framework.

Related Experiment Videos

Clinical and laboratory directions for ovarian cancer research

Related Concept Videos

Related Articles